Variant report
Variant | esv3329980 |
---|---|
Chromosome Location | chr10:56066046-56068044 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150600421 | chr10:56066066-56066067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191972229 | chr10:56066082-56066083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182702360 | chr10:56066087-56066088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576607616 | chr10:56066089-56066090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114090360 | chr10:56066124-56066125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187649251 | chr10:56066148-56066149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572056730 | chr10:56066189-56066190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540981812 | chr10:56066190-56066191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12250646 | chr10:56066200-56066201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190034742 | chr10:56066207-56066208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138916887 | chr10:56066251-56066252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574043030 | chr10:56066253-56066254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71299260 | chr10:56066265-56066266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376704714 | chr10:56066266-56066267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563468824 | chr10:56066276-56066277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142717997 | chr10:56066325-56066326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548912623 | chr10:56066326-56066327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147347412 | chr10:56066381-56066382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs56878217 | chr10:56066399-56066400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372692718 | chr10:56066403-56066404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547350467 | chr10:56066407-56066408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570549170 | chr10:56066426-56066427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539726173 | chr10:56066548-56066549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145150159 | chr10:56066556-56066557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576554046 | chr10:56066566-56066567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs57016910 | chr10:56066579-56066580 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs184326434 | chr10:56067236-56067237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547515220 | chr10:56067281-56067282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142921757 | chr10:56067288-56067289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533197053 | chr10:56067291-56067292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375289910 | chr10:56067296-56067297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570284440 | chr10:56067306-56067307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535796287 | chr10:56067350-56067351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555894871 | chr10:56067407-56067408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7921798 | chr10:56067437-56067438 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs189312376 | chr10:56067438-56067439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534704695 | chr10:56067550-56067551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151127490 | chr10:56067553-56067554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573564374 | chr10:56067562-56067563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116206896 | chr10:56067563-56067564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577820937 | chr10:56067640-56067641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191706207 | chr10:56067644-56067645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184340234 | chr10:56067653-56067654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573841845 | chr10:56067654-56067655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141404401 | chr10:56067681-56067682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559479654 | chr10:56067727-56067728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528320162 | chr10:56067729-56067730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143873130 | chr10:56067735-56067736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4397746 | chr10:56067742-56067743 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56058800-56066400 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr10:56066400-56066600 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr10:56067200-56067800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |